Nadolol

CHEMBL521606 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
309.4 g/mol
LogP
0.7
Phase
4

This beta-blocker medication is used to treat high blood pressure and angina, and to control abnormal heart rhythms including atrial fibrillation. It works by slowing the heart rate and reducing the force of heart contractions, which lowers blood pressure and decreases the heart's workload.

Peso molecular

309,4000 g/mol

LogP

0,70

TPSA

82,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2

InChI

InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3

Molecular Formula

C17H27NO4

HBD / HBA

4 / 5

Enlaces Rotables

6

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This beta-blocker medication is used to treat high blood pressure and angina, and to control abnormal heart rhythms including atrial fibrillation. It works by slowing the heart rate and reducing the force of heart contractions, which lowers blood pressure and decreases the heart's workload.

Yes, Nadolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL521606. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 39147. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.